AVENUE THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2016 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Avenue Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2016 to Q4 2024.
  • Avenue Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $522K, a 70% increase year-over-year.
  • Avenue Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $1.24M, a 36.4% increase year-over-year.
  • Avenue Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1.24M, a 36.4% increase from 2023.
  • Avenue Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $906K, a 39.6% increase from 2022.
  • Avenue Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $649K.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $1.24M $522K +$215K +70% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 $1.02M $331K -$230K -41% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $1.25M $192K +$165K +611% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $1.09M $191K +$180K +1636% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $906K $307K Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 $561K +$536K +2144% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $27K -$16K -37.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $11K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 $25K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $43K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2018 $100K $0 -$100K -100% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-03
Q4 2017 $200K $0 -$79K -100% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-01
Q3 2017 $279K $0 -$70K -100% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $349K $100K +$30K +42.9% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-11
Q1 2017 $319K $100K +$19K +23.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 $300K $79K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 $70K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $70K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 $81K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.